P482 Burden of serious fungal infections in India

POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: : Fungal disease is frequent in India but its incidence and prevalence are unclear. Literature searches yielded over 2900 papers; 434 papers with incidence/prevalence/proportion data were analyzed. Deterministic modeling allowed annual incident and prevalence estimates for multiple life and sight-threatening infections with significant morbidity. An estimated 55 916 148 of 1 393 400 000 people in India (4.01/100 000) suffer from a serious fungal disease. The prevalence (in millions) of recurrent vulvovaginal candidiasis is 24.3, allergic bronchopulmonary aspergillosis (ABPA) is 2.0, tinea capitis in school-age children is 25, severe asthma with fungal sensitization of 1.36, chronic pulmonary aspergillosis of 1.75 and chronic fungal rhinosinusitis of 1.52. The annual incidence of Pneumocystis pneumonia (58 400), invasive aspergillosis (250 900), mucormycosis (195 000), esophageal candidiasis in HIV (266 600), candidemia (18 800), fungal keratitis (1 017 100) and cryptococcal meningitis (11 300) were also determined. Histoplasmosis, talaromycosis, mycetoma, and chromoblastomycosis are less frequent. India's fungal burden is high and under-appreciated in clinical practice. See Figures below.